Subscribe
shutterstock_1169047330_markvanscyoc-1
markvanscyoc / shutterstock.com
6 September 2022Big PharmaStaff Writer

USPTO unveils tool to access key FDA data

Web page reveals information concerning patent term extension applications | President Joe Biden urged collaboration between USPTO and FDA.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.


Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024

Editor's picks

Americas
Trump’s return sparks calls for pro-patent agenda
5 December 2024
Americas
Comparing life sciences IP in Brazil and the US
28 November 2024
Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024

More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More on this story

Big Pharma
USPTO and FDA unite to tackle drug pricing
7 July 2022   The US Patent and Trademark Office and Food and Drug Administration have partnered to facilitate access to affordable drugs.
article
USPTO told to avoid negative focus on patent thickets
28 February 2023   Pharma trade body highlighted negative narratives involving continuation patents | Such IP “essential for ongoing research and development” | USPTO requested comments following criticism of patent thickets.

More features

Fed Circ orders Teva to delist five patents from Orange Book
Sarepta wins $115M in patent dispute over muscular dystrophy drug
Novartis shields eye-drop patent at European Patent Office
CREATES Act unfairly tips the scales to generics
LSPN launches its first-ever US awards to celebrate life sciences leaders
Pharma giants seek closure on COVID-19 vaccine rows
How Inhibrx defended a $450m damages suit
Foley & Lardner adds litigation and transaction expert in New York